PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
3 hedge funds and large institutions have $2.29M invested in PureTech Health in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.47% less ownership
Funds ownership: 0.5% → 0.03% (-0.47%)
25% less funds holding
Funds holding: 4 → 3 (-1)
67% less capital invested
Capital invested by funds: $6.9M → $2.29M (-$4.6M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| 1 |
Jane Street
New York
|
+$38.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$30 |
Top Sellers
| 1 |
AIC
AWM Investment Company
New York
|
-$38.5M |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$207K |
PRTC Hedge Fund Activity: Q1 2023 in Review
3 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q1 2023, worth a combined $2.29M — down 67% from $6.9M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PRTC and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Jane Street, adding an estimated $38.2K. The largest seller was AWM Investment Company, cutting an estimated $38.5M.
- 3 institutional investors held PureTech Health (PRTC) as of Q1 2023, down from 4 in Q4 2022.
- Funds reported $2.29M of PureTech Health stock for Q1 2023, down 67% quarter-over-quarter.
- 0 funds opened new PureTech Health positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest PureTech Health buyer in Q1 2023 was Jane Street, an estimated $38.2K added.
- The largest PureTech Health seller in Q1 2023 was AWM Investment Company, an estimated $38.5M sold.
Based on aggregated 13F filings for Q1 2023.